Reference
Giusti R, et al. Complete Tumor Response with Afatinib 20 mg Daily in EGFR-Mutated Non-small Cell Lung Cancer: A Case Report. Clinical Drug Investigation 37: 581-585, No. 6, Jun 2017. Available from: URL: http://doi.org/10.1007/s40261-017-0515-2 - Italy
Rights and permissions
About this article
Cite this article
Afatinib. Reactions Weekly 1677, 15 (2017). https://doi.org/10.1007/s40278-017-38293-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-38293-1